berberine has been researched along with Neoplasm Metastasis in 20 studies
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine is a natural compound extracted from Coptidis rhizoma, and accumulating proof has shown its potent anti-tumor properties with diverse action on melanoma cells, including inhibiting cancer viability, blocking cell cycle and migration." | 7.83 | Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. ( Du, B; Kou, Y; Li, B; Li, H; Li, L; Tan, Y; Wang, K, 2016) |
| "Effects of coptisine on highly metastatic human breast cancer cell MDA-MB-231 proliferation were evaluated by trypan blue assay and on cell adhesion, migration and invasion by gelatin adhesion, wound-healing and matrigel invasion chamber assays, respectively." | 7.80 | Suppression of human breast cancer cell metastasis by coptisine in vitro. ( Cao, SP; Chen, SH; Li, J; Qiu, DM; Xia, XL, 2014) |
| "In this study, we investigated the anti-metastasis mechanisms of berberine in human melanoma cancer A375." | 5.48 | Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro. ( Chueh, FS; Chung, JG; Huang, AC; Huang, WW; Huang, YP; Lai, KC; Liu, JF; Maraming, P; Peng, SF, 2018) |
| "Berberine could suppress the transcription level of Id-1 through inhibiting its promotor activity." | 5.42 | Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. ( Cheung, KC; Cheung, YC; Feng, Y; Lui, VW; Man, K; Tsang, CM; Tsao, SW, 2015) |
| "Berberine is a natural compound extracted from Coptidis rhizoma, and accumulating proof has shown its potent anti-tumor properties with diverse action on melanoma cells, including inhibiting cancer viability, blocking cell cycle and migration." | 3.83 | Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. ( Du, B; Kou, Y; Li, B; Li, H; Li, L; Tan, Y; Wang, K, 2016) |
| "Effects of coptisine on highly metastatic human breast cancer cell MDA-MB-231 proliferation were evaluated by trypan blue assay and on cell adhesion, migration and invasion by gelatin adhesion, wound-healing and matrigel invasion chamber assays, respectively." | 3.80 | Suppression of human breast cancer cell metastasis by coptisine in vitro. ( Cao, SP; Chen, SH; Li, J; Qiu, DM; Xia, XL, 2014) |
| "Berberine is an effective component extracted from the rhizomes of coptis chinensis and phellodendron chinensis." | 1.62 | Berberine inhibited metastasis through miR-145/MMP16 axis in vitro. ( Jiang, Y; Li, J; Pei, M; Wu, L; Zhang, S, 2021) |
| "KRas is frequently mutated in pancreatic cancers." | 1.62 | GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals. ( Abrams, SL; Akula, SM; Candido, S; Cervello, M; Cocco, L; Duda, P; Falzone, L; Gizak, A; Libra, M; Martelli, AM; McCubrey, JA; Meher, AK; Montalto, G; Rakus, D; Ratti, S; Ruvolo, P; Steelman, LS, 2021) |
| "The biological function of BBR in endometrial cancer (EC) and the underlying molecular mechanisms, however, remain unknown." | 1.48 | Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. ( Wang, Y; Zhang, S, 2018) |
| "In this study, we investigated the anti-metastasis mechanisms of berberine in human melanoma cancer A375." | 1.48 | Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro. ( Chueh, FS; Chung, JG; Huang, AC; Huang, WW; Huang, YP; Lai, KC; Liu, JF; Maraming, P; Peng, SF, 2018) |
| "Berberine could suppress the transcription level of Id-1 through inhibiting its promotor activity." | 1.42 | Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. ( Cheung, KC; Cheung, YC; Feng, Y; Lui, VW; Man, K; Tsang, CM; Tsao, SW, 2015) |
| "Berberine has several anti-inflammation and anticancer biologic effects." | 1.40 | Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. ( Chen, KS; Chen, PN; Chu, SC; Hsu, LS; Su, MY; Yu, CC, 2014) |
| "Berberine treatment also decreased various biochemical parameters associated with lung metastasis." | 1.38 | Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. ( Hamsa, TP; Kuttan, G, 2012) |
| "Berberine is an active ingredient extracted from Coptidis rhizoma which has been used for centuries as a traditional Chinese medicine for treatment of inflammatory diseases." | 1.35 | Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. ( Cheung, AL; Cheung, PY; Ching, YP; Di, K; Feng, Y; Hau, PM; Lau, EP; Tong, Y; Tsang, CM; Tsao, SW; Wan, TS; Wong, YC, 2009) |
| "Berberine treatment in vivo resulted in a 51." | 1.35 | Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. ( Cao, Y; Chen, Y; Deng, F; Duan, C; He, Z; Huang, D; Liu, S; Meng, J; Tang, F; Tian, D; Wang, D; Wang, L; Wang, W; Wu, B; Wu, Y; Xie, C; Zhu, F, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CS | 1 |
| Tan, HY | 1 |
| Zhang, C | 1 |
| Chan, YT | 1 |
| Zhang, ZJ | 1 |
| Man, K | 2 |
| Yuen, MF | 1 |
| Wang, N | 1 |
| Feng, Y | 3 |
| Liu, J | 1 |
| Luo, X | 1 |
| Guo, R | 1 |
| Jing, W | 1 |
| Lu, H | 1 |
| Li, J | 3 |
| Zhang, S | 2 |
| Wu, L | 1 |
| Pei, M | 1 |
| Jiang, Y | 1 |
| Zhao, Y | 1 |
| Yang, X | 1 |
| Zhao, J | 1 |
| Gao, M | 1 |
| Zhang, M | 1 |
| Shi, T | 1 |
| Zhang, F | 1 |
| Zheng, X | 1 |
| Pan, Y | 1 |
| Shao, D | 1 |
| He, K | 1 |
| Chen, L | 1 |
| Abrams, SL | 1 |
| Akula, SM | 1 |
| Meher, AK | 1 |
| Steelman, LS | 1 |
| Gizak, A | 1 |
| Duda, P | 1 |
| Rakus, D | 1 |
| Martelli, AM | 1 |
| Ratti, S | 1 |
| Cocco, L | 1 |
| Montalto, G | 1 |
| Cervello, M | 1 |
| Ruvolo, P | 1 |
| Libra, M | 1 |
| Falzone, L | 1 |
| Candido, S | 1 |
| McCubrey, JA | 1 |
| Wang, Y | 1 |
| Liu, JF | 1 |
| Lai, KC | 1 |
| Peng, SF | 1 |
| Maraming, P | 1 |
| Huang, YP | 1 |
| Huang, AC | 1 |
| Chueh, FS | 1 |
| Huang, WW | 1 |
| Chung, JG | 1 |
| Qi, HW | 1 |
| Xin, LY | 1 |
| Xu, X | 1 |
| Ji, XX | 1 |
| Fan, LH | 1 |
| Qiu, DM | 1 |
| Chen, SH | 1 |
| Cao, SP | 1 |
| Xia, XL | 1 |
| Chu, SC | 1 |
| Yu, CC | 1 |
| Hsu, LS | 1 |
| Chen, KS | 1 |
| Su, MY | 1 |
| Chen, PN | 1 |
| Luo, Z | 1 |
| Zeng, W | 1 |
| Tang, W | 1 |
| Long, T | 1 |
| Zhang, J | 1 |
| Xie, X | 1 |
| Kuang, Y | 1 |
| Chen, M | 1 |
| Su, J | 1 |
| Chen, X | 1 |
| Tsang, CM | 2 |
| Cheung, KC | 1 |
| Cheung, YC | 1 |
| Lui, VW | 1 |
| Tsao, SW | 2 |
| Liu, X | 1 |
| Ji, Q | 1 |
| Ye, N | 1 |
| Sui, H | 1 |
| Zhou, L | 1 |
| Zhu, H | 1 |
| Fan, Z | 1 |
| Cai, J | 1 |
| Li, Q | 1 |
| Kou, Y | 1 |
| Li, L | 1 |
| Li, H | 1 |
| Tan, Y | 1 |
| Li, B | 1 |
| Wang, K | 1 |
| Du, B | 1 |
| Lau, EP | 1 |
| Di, K | 1 |
| Cheung, PY | 1 |
| Hau, PM | 1 |
| Ching, YP | 1 |
| Wong, YC | 1 |
| Cheung, AL | 1 |
| Wan, TS | 1 |
| Tong, Y | 1 |
| Tang, F | 2 |
| Wang, D | 1 |
| Duan, C | 1 |
| Huang, D | 2 |
| Wu, Y | 1 |
| Chen, Y | 2 |
| Wang, W | 2 |
| Xie, C | 2 |
| Meng, J | 2 |
| Wang, L | 2 |
| Wu, B | 1 |
| Liu, S | 1 |
| Tian, D | 1 |
| Zhu, F | 1 |
| He, Z | 1 |
| Deng, F | 1 |
| Cao, Y | 1 |
| Feng, Z | 1 |
| Hamsa, TP | 1 |
| Kuttan, G | 1 |
| Tillhon, M | 1 |
| Guamán Ortiz, LM | 1 |
| Lombardi, P | 1 |
| Scovassi, AI | 1 |
| Matsuo, M | 1 |
| Sakurai, H | 1 |
| Koizumi, K | 1 |
| Saiki, I | 1 |
1 review available for berberine and Neoplasm Metastasis
| Article | Year |
|---|---|
Berberine: new perspectives for old remedies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Auto | 2012 |
19 other studies available for berberine and Neoplasm Metastasis
| Article | Year |
|---|---|
Berberine suppresses metastasis and recurrence of hepatocellular carcinoma by targeting circulating tumour cells: abridged secondary publication.
Topics: Berberine; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Neoplasm Metastasis | 2022 |
Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism.
Topics: Berberine; Cell Survival; Citrates; Humans; Metabolome; Metabolomics; Neoplasm Metastasis; Pancreati | 2020 |
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.
Topics: Berberine; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 16; MicroRNAs; Neoplasm Metast | 2021 |
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1.
Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques | 2021 |
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Topics: Adenocarcinoma; Adenylate Kinase; Antineoplastic Agents; bcl-X Protein; Berberine; Biphenyl Compound | 2021 |
Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2.
Topics: Animals; Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygena | 2018 |
Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro.
Topics: Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Neop | 2018 |
Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis.
Topics: Animals; Apoptosis; Berberine; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferatio | 2014 |
Suppression of human breast cancer cell metastasis by coptisine in vitro.
Topics: Berberine; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Col | 2014 |
Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells.
Topics: Animals; Berberine; beta Catenin; Cell Line, Tumor; Cell Movement; Chickens; Chorioallantoic Membran | 2014 |
CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.
Topics: Apoptosis; Basigin; Berberine; Cell Line, Tumor; Cell Nucleus; Electron Transport Complex I; Gene Ex | 2014 |
Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
Topics: Animals; Berberine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression | 2015 |
Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Cell Line, Tumor; Cell Movement; Colon; Color | 2015 |
Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.
Topics: Animals; Antineoplastic Agents; Berberine; Chromones; Epithelial-Mesenchymal Transition; Gene Expres | 2016 |
Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Do | 2009 |
Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567.
Topics: Animals; Antineoplastic Agents; Berberine; Cell Line, Tumor; Cytoskeletal Proteins; Enzyme Activatio | 2009 |
Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Cell Line, Tumor; Cytoskeletal Proteins; Humans; Nasop | 2011 |
Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells.
Topics: Activating Transcription Factor 2; Animals; Antineoplastic Agents, Phytogenic; Berberine; Cell Line, | 2012 |
Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells.
Topics: Animals; Berberine; Capillaries; Cell Adhesion; Cell Line, Tumor; Cell Survival; Curcumin; Dose-Resp | 2007 |